Skip to main content
Disease Markers logoLink to Disease Markers
. 2002 Jun 7;17(2):115–120. doi: 10.1155/2001/239602

ANX7 as a Bio-Marker in Prostate and Breast Cancer Progression

Meera Srivastava 1,*, Lukas Bubendorf 2,5, Lisa Nolan 1, Mirta Glasman 1, Ximena Leighton 1, Georgina Miller 3, Wilfred Fehrle 4, Mark Raffeld 4, Ofer Eidelman 1, Olli P Kallioniemi 2, Shiv Srivastava 6, Harvey B Pollard 1
PMCID: PMC3851363  PMID: 11673658

Abstract

The ANX7 gene codes for a Ca2+-activated GTPase, which has been implicated in both exocytotic secretion in cells and control of growth. In this review, we summarize information regarding increased tumor frequency in the Anx7 knockout mice, ANX7 growth suppression of human cancer cell lines, and ANX7 expression in human tumor tissue micro-arrays. The loss of ANX7 is significant in metastatic and hormone refractory prostate cancer compared to benign prostatic hyperplasia. In addition, ANX7 expression has prognostic value for predicting survival of breast cancer patients.

Full Text

The Full Text of this article is available as a PDF (2.7 MB).


Articles from Disease Markers are provided here courtesy of Wiley

RESOURCES